These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11182627)

  • 1. A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interaction.
    Ikeda Y; Handa M; Murata M; Goto S
    Haemostasis; 2000; 30 Suppl 3():44-52. PubMed ID: 11182627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of the interaction between von Willebrand factor and platelet GPIb/IX/V.
    Gresele P; Momi S
    Handb Exp Pharmacol; 2012; (210):287-309. PubMed ID: 22918736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs.
    De Meyer SF; Vanhoorelbeke K; Ulrichts H; Staelens S; Feys HB; Salles I; Fontayne A; Deckmyn H
    Cardiovasc Hematol Disord Drug Targets; 2006 Sep; 6(3):191-207. PubMed ID: 17017902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of AJW200, a humanized monoclonal antibody to von Willebrand factor, in monkeys.
    Kageyama S; Yamamoto H; Nakazawa H; Matsushita J; Kouyama T; Gonsho A; Ikeda Y; Yoshimoto R
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):187-92. PubMed ID: 11788481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
    Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F
    Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting von Willebrand factor and platelet glycoprotein Ib receptor.
    Firbas C; Siller-Matula JM; Jilma B
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1689-701. PubMed ID: 21108551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shear-dependent functions of the interaction between soluble von Willebrand factor and platelet glycoprotein Ib in mural thrombus formation on a collagen surface.
    Sugimoto M; Tsuji S; Kuwahara M; Matsui H; Miyata S; Fujimura Y; Yoshioka A
    Int J Hematol; 1999 Jan; 69(1):48-53. PubMed ID: 10641443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
    Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting platelet GPIbβ reduces platelet adhesion, GPIb signaling and thrombin generation and prevents arterial thrombosis.
    Maurer E; Tang C; Schaff M; Bourdon C; Receveur N; Ravanat C; Eckly A; Hechler B; Gachet C; Lanza F; Mangin PH
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1221-9. PubMed ID: 23559635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a VWF peptide antagonist that blocks platelet adhesion under high shear conditions by selectively inhibiting the VWF-collagen interaction.
    Szanto T; Vanhoorelbeke K; Toth G; Vandenbulcke A; Toth J; Noppe W; Deckmyn H; Harsfalvi J
    J Thromb Haemost; 2009 Oct; 7(10):1680-7. PubMed ID: 19624458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for platelet glycoprotein Ib-IX and effects of its inhibition in endotoxemia-induced thrombosis, thrombocytopenia, and mortality.
    Yin H; Stojanovic-Terpo A; Xu W; Corken A; Zakharov A; Qian F; Pavlovic S; Krbanjevic A; Lyubimov AV; Wang ZJ; Ware J; Du X
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2529-37. PubMed ID: 24051142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of a human monoclonal antibody that interacts with a sulfated tyrosine-containing epitope of the GPIb receptor and inhibits platelet functions.
    Hagay Y; Lahav J; Levanon A; Varon D; Brill A; Panet A
    Mol Immunol; 2006 Feb; 43(5):443-53. PubMed ID: 16337487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
    Oostingh GJ; Pozgajova M; Ludwig RJ; Krahn T; Boehncke WH; Nieswandt B; Schön MP
    Haematologica; 2007 Apr; 92(4):502-12. PubMed ID: 17488661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of von Willebrand factor-GPIb/IX/V interactions as a strategy to prevent arterial thrombosis.
    Bonnefoy A; Vermylen J; Hoylaerts MF
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):257-69. PubMed ID: 15030285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
    Ji S; Jiang M; Yan B; Shen F; He Y; Wan A; Xia L; Ruan C; Zhao Y
    J Hematol Oncol; 2017 May; 10(1):111. PubMed ID: 28526067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet physiology and thrombosis.
    Andrews RK; Berndt MC
    Thromb Res; 2004; 114(5-6):447-53. PubMed ID: 15507277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.